Performance evaluation of newly developed fluorescence immunoassay-based interferon-gamma release assay for the diagnosis of latent tuberculosis infection in healthcare workers

Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/9203

Full metadata record

DC Field	Value	Language
dc.contributor.author	Kweon, Oh Joo	-
dc.contributor.author	Kwan Lim, Yong	-
dc.contributor.author	Ryoun Kim, Hye	-
dc.contributor.author	-Hyoung Kim, Tae	-
dc.contributor.author	Lee, Mi-Kyung	-
dc.date.accessioned	2024-12-18T02:39:57Z	-
dc.date.available	2024-12-18T02:39:57Z	-
dc.date.issued	2022-04-01	-
dc.identifier.issn	1684-1182	-
dc.identifier.uri	http://localhost:8080/xmlui/handle/123456789/9203	-
dc.description.abstract	Abstract The ichroma IGRA-TB (Boditech Med Inc., Chuncheon, Republic of Korea) is an automated fluorescent immunoassay-based point-of-care interferon-gamma release assay for detecting latent tuberculosis infection. We evaluated this assay with 408 health care workers, and demonstrated its acceptable performances comparing to QuantiFERON-TB Gold-Plus (QFTPlus; Qiagen, Germantown, MD).	en_US
dc.language.iso	en	en_US
dc.publisher	Elsevier Taiwan LLC	en_US
dc.subject	ichroma IGRA-TB;	en_US
dc.subject	QuantiFERON-TB Gold-plus;	en_US
dc.subject	Interferon-gamma release assay;	en_US
dc.subject	Latent tuberculosis infection	en_US
dc.title	Performance evaluation of newly developed fluorescence immunoassay-based interferon-gamma release assay for the diagnosis of latent tuberculosis infection in healthcare workers	en_US
dc.type	Article	en_US
Appears in Collections:	VOL 55 NO 2 2022

Files in This Item:

File	Description	Size	Format
328-331.pdf		334.52 kB	Adobe PDF	View/Open

DSpace JSPUI